These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 11713846)

  • 1. The choice of first-line therapy: rationale for low-dose combinations of an angiotensin converting enzyme inhibitor and a diuretic.
    Opie LH; Messerli FH
    J Hypertens Suppl; 2001 Sep; 19(3):S17-21. PubMed ID: 11713846
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combination of converting enzyme inhibitor with diuretic for the treatment of hypertension.
    Townsend RR; Holland OB
    Arch Intern Med; 1990 Jun; 150(6):1175-83. PubMed ID: 2191634
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Difficult-to-treat hypertensive populations: focus on African-Americans and people with type 2 diabetes.
    Flack JM; Hamaty M
    J Hypertens Suppl; 1999 Feb; 17(1):S19-24. PubMed ID: 10340840
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Which is the optimal antihypertensive combination in different diseases, a renin- angiotensin-aldosterone system inhibitor with a diuretic or with a calcium channel blocker?
    Riva N; Lip GY
    Curr Pharm Des; 2013; 19(21):3753-65. PubMed ID: 23286431
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Blood pressure effects of high-dose amlodipine-benazepril combination in Black and White hypertensive patients not controlled on monotherapy.
    Chrysant SG
    Drugs R D; 2012 Jun; 12(2):57-64. PubMed ID: 22571394
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Clinical assessment of metabolic effects of antihypertensive therapy].
    Tkacheva ON; Shumbutova AIu; Novikova IM; Samsonenko NS; Guseva KIu
    Kardiologiia; 2008; 48(3):34-8. PubMed ID: 18429754
    [No Abstract]   [Full Text] [Related]  

  • 7. Pharmacological interventions for hypertension in children.
    Chaturvedi S; Lipszyc DH; Licht C; Craig JC; Parekh R
    Cochrane Database Syst Rev; 2014 Feb; 2014(2):CD008117. PubMed ID: 24488616
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Update on the management of hypertension: recent clinical trials and the JNC 7.
    Moser M
    J Clin Hypertens (Greenwich); 2004 Oct; 6(10 Suppl 2):4-13. PubMed ID: 15470293
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rationale for angiotensin II receptor blockers in patients with low-renin hypertension.
    Jamerson KA
    Am J Kidney Dis; 2000 Sep; 36(3 Suppl 1):S24-30. PubMed ID: 10986156
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Managing hypertension using combination therapy.
    Frank J
    Am Fam Physician; 2008 May; 77(9):1279-86. PubMed ID: 18540493
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Choice of ACE inhibitor combinations in hypertensive patients with type 2 diabetes: update after recent clinical trials.
    Reboldi G; Gentile G; Angeli F; Verdecchia P
    Vasc Health Risk Manag; 2009; 5(1):411-27. PubMed ID: 19475778
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination therapy as first-line treatment for hypertension.
    Crawford MH
    Am J Cardiovasc Drugs; 2009; 9(1):1-6. PubMed ID: 19178127
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Very-low-dose combination: a first-line choice for the treatment of hypertension?
    Waeber B
    J Hypertens Suppl; 2003 Jun; 21(3):S3-10. PubMed ID: 12929469
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Resistant Hypertension: Which Agent?
    Prosser HCG; Azzam O; Schlaich MP
    Heart Lung Circ; 2018 Aug; 27(8):911-916. PubMed ID: 29526418
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy in hypertension.
    Gorostidi M; de la Sierra A
    Adv Ther; 2013 Apr; 30(4):320-36. PubMed ID: 23553510
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Description of antihypertensive use in patients with resistant hypertension prescribed four or more agents.
    Hanselin MR; Saseen JJ; Allen RR; Marrs JC; Nair KV
    Hypertension; 2011 Dec; 58(6):1008-13. PubMed ID: 22042809
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Comparison of different therapeutic strategies in hypertension: a low-dose combination of perindopril/indapamide versus a sequential monotherapy or a stepped-care approach.
    Mourad JJ; Waeber B; Zannad F; Laville M; Duru G; Andréjak M;
    J Hypertens; 2004 Dec; 22(12):2379-86. PubMed ID: 15614033
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Equivalent antihypertensive effects of combination therapy using diuretic + calcium antagonist compared with diuretic + ACE inhibitor.
    Elliott WJ; Polascik TB; Murphy MB
    J Hum Hypertens; 1990 Dec; 4(6):717-23. PubMed ID: 2096214
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of combination therapy in the treatment of hypertension.
    Moser M; Black HR
    Am J Hypertens; 1998 Jun; 11(6 Pt 2):73S-78S; discussion 95S-100S. PubMed ID: 9655566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Long-term efficacy of a new, fixed, very-low-dose angiotensin-converting enzyme-inhibitor/diuretic combination as first-line therapy in elderly hypertensive patients.
    Chalmers J; Castaigne A; Morgan T; Chastang C
    J Hypertens; 2000 Mar; 18(3):327-37. PubMed ID: 10726720
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.